Jean-Simon Diallo Selected Research

Jean-Simon Diallo Research Topics

Disease

56	Neoplasms (Cancer) 05/2024 - 05/2006
13	Infections 11/2023 - 12/2010
9	Prostatic Neoplasms (Prostate Cancer) 01/2011 - 05/2006
6	COVID-19 12/2023 - 01/2021
5	Virus Diseases (Viral Diseases) 11/2023 - 06/2010
5	Vesicular Stomatitis 01/2023 - 12/2010
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2016
4	Melanoma (Melanoma, Malignant) 01/2023 - 03/2021
3	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2009
2	Brain Neoplasms (Brain Tumor) 05/2024 - 02/2013
2	Inflammation (Inflammations) 01/2024 - 05/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2018
2	Multiple Sclerosis 01/2023 - 01/2018
2	Leukemia 01/2021 - 07/2013
2	Vaccinia 08/2015 - 12/2010
2	Prostatic Intraepithelial Neoplasia 12/2007 - 05/2006
2	Margins of Excision 12/2007 - 08/2007
1	Liposarcoma 01/2024
1	Herpes Simplex 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Malaria 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Triple Negative Breast Neoplasms 01/2018

Drug/Important Bio-Agent (IBA)

19	Antiviral Agents (Antivirals)IBA 05/2024 - 09/2008
11	VaccinesIBA 12/2023 - 09/2012
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2024 - 09/2012
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2010
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 10/2011
5	InterferonsIBA 03/2021 - 12/2010
5	Hormones (Hormone)IBA 05/2009 - 05/2006
4	AntigensIBA 01/2024 - 04/2013
4	CytokinesIBA 01/2016 - 05/2009
4	AndrogensIBA 05/2008 - 09/2006
3	VanadiumIBA 01/2022 - 01/2018
3	Histone Deacetylase InhibitorsIBA 04/2013 - 09/2008
3	ErbB Receptors (EGF Receptor)IBA 04/2012 - 05/2006
3	Androgen Receptors (Androgen Receptor)IBA 05/2008 - 09/2006
2	Peptides (Polypeptides)IBA 05/2023 - 08/2011
2	Interleukin-12 (IL 12)IBA 05/2023 - 01/2022
2	Dimethyl FumarateIBA 01/2023 - 01/2018
2	maleic acid (maleate)IBA 01/2023 - 01/2018
2	EstersIBA 01/2023 - 01/2018
2	Vanadates (Orthovanadate)IBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2009
2	Interferon Type IIBA 03/2021 - 04/2012
2	Firefly LuciferasesIBA 09/2014 - 06/2011
2	Phytic Acid (Inositol Hexaphosphate)IBA 01/2011 - 09/2006
2	I-kappa B KinaseIBA 05/2009 - 01/2007
2	NF-kappa B (NF-kB)IBA 05/2007 - 01/2007
1	4-octyl itaconateIBA 05/2024
1	itaconic acidIBA 05/2024
1	Cysteine (L-Cysteine)FDA Link 05/2024
1	COVID-19 VaccinesIBA 12/2023
1	EpitopesIBA 12/2023
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2023
1	pevonedistatIBA 11/2023
1	ChlorotoxinIBA 05/2023
1	Ado-Trastuzumab EmtansineIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	Colistin (Coly-Mycin)FDA Link 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	bifonazoleIBA 01/2022
1	cyclic diadenosine phosphateIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	proguanil drug combination atovaquone (malarone)FDA Link 11/2021
1	Atovaquone (Mepron)FDA Link 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2021
1	vanadyl sulfateIBA 03/2021
1	Protein Tyrosine PhosphatasesIBA 03/2021
1	AntibodiesIBA 12/2020
1	OvalbuminIBA 12/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	SaltsIBA 01/2019
1	CationsIBA 01/2019
1	LigandsIBA 01/2019
1	Drug CombinationsIBA 10/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Vanadium CompoundsIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	MTOR InhibitorsIBA 01/2018
1	Eukaryotic Initiation Factor-4EIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Cancer VaccinesIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018

Therapy/Procedure

21	Therapeutics 11/2023 - 01/2007
15	Immunotherapy 01/2024 - 04/2013
12	Oncolytic Virotherapy 05/2024 - 02/2010
3	Prostatectomy (Retropubic Prostatectomy) 05/2008 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
1	RNAi Therapeutics 11/2023
1	Intranasal Administration 01/2022
1	Chemoprevention 11/2021
1	Radiotherapy 01/2021